Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TERLIPRESSIN Cause Thrombophlebitis superficial? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Thrombophlebitis superficial have been filed in association with TERLIPRESSIN (Terlivaz). This represents 4.7% of all adverse event reports for TERLIPRESSIN.

5
Reports of Thrombophlebitis superficial with TERLIPRESSIN
4.7%
of all TERLIPRESSIN reports
0
Deaths
5
Hospitalizations

How Dangerous Is Thrombophlebitis superficial From TERLIPRESSIN?

Of the 5 reports, 5 (100.0%) required hospitalization.

Is Thrombophlebitis superficial Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TERLIPRESSIN. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does TERLIPRESSIN Cause?

Drug ineffective (26) Electrocardiogram qt prolonged (12) Acute respiratory distress syndrome (9) Cardiac arrest (9) Toxicity to various agents (9) Acute kidney injury (8) Multiple organ dysfunction syndrome (8) Eosinophilia (7) Lung disorder (7) Death (6)

What Other Drugs Cause Thrombophlebitis superficial?

DROSPIRENONE\ETHINYL ESTRADIOL (160) LENALIDOMIDE (121) ETHINYL ESTRADIOL\ETONOGESTREL (93) RIVAROXABAN (82) YAZ (78) YASMIN (65) TESTOSTERONE (62) HUMAN IMMUNOGLOBULIN G (43) ADALIMUMAB (40) CAPECITABINE (29)

Which TERLIPRESSIN Alternatives Have Lower Thrombophlebitis superficial Risk?

TERLIPRESSIN vs TESAMORELIN TERLIPRESSIN vs TESTOSTERONE TERLIPRESSIN vs TESTOSTERONE CYPIONATE TERLIPRESSIN vs TESTOSTERONE ENANTHATE TERLIPRESSIN vs TESTOSTERONE UNDECANOATE

Related Pages

TERLIPRESSIN Full Profile All Thrombophlebitis superficial Reports All Drugs Causing Thrombophlebitis superficial TERLIPRESSIN Demographics